Locations:
Search
Phase 3 EXPAND trial suggests potential utility of siponimod
Video profiles two key innovations and their impact
How and why to assess and treat
Neural-machine interface makes users feel that an artificial hand is their own
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Novel monoclonal antibody takes aim at alpha-synuclein clusters
Cleveland Clinic offers an abundance of direct delivery trials
New article reviews time-to-treatment data and looks ahead to emerging outcomes and cost studies
Neurological Institute strategies take a distinctly interdisciplinary tack
Cleveland Clinic’s head of epilepsy surgery reflects on two decades of major progress
Most substantial reversal of amyloid deposition in an animal study to date
Advertisement
Advertisement